Literature DB >> 16597486

ERK3 associates with MAP2 and is involved in glucose-induced insulin secretion.

Gabriel F Anhê1, Andréa S Torrão, Tatiane C A Nogueira, Luciana C Caperuto, Maria E C Amaral, Mayrin C Medina, Anna K Azevedo-Martins, Angelo R Carpinelli, Carla R O Carvalho, Rui Curi, Antonio C Boschero, Silvana Bordin.   

Abstract

The adaptation of pancreatic islets to pregnancy includes increased beta cell proliferation, expansion of islet mass, and increased insulin synthesis and secretion. Most of these adaptations are induced by prolactin (PRL). We have previously described that in vitro PRL treatment increases ERK3 expression in isolated rat pancreatic islets. This study shows that ERK3 is also upregulated during pregnancy. Islets from pregnant rats treated with antisense oligonucleotide targeted to the PRL receptor displayed a significant reduction in ERK3 expression. Immunohistochemical double-staining showed that ERK3 expression is restricted to pancreatic beta cells. Transfection with antisense oligonucleotide targeted to ERK3 abolished the insulin secretion stimulated by glucose in rat islets and by PMA in RINm5F cells. Therefore, we examined the participation of ERK3 in the activation of a cellular target involved in secretory events, the microtubule associated protein MAP2. PMA induced ERK3 phosphorylation that was companied by an increase in ERK3/MAP2 association and MAP2 phosphorylation. These observations provide evidence that ERK3 is involved in the regulation of stimulus-secretion coupling in pancreatic beta cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597486     DOI: 10.1016/j.mce.2006.02.012

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality.

Authors:  Sonia Klinger; Benjamin Turgeon; Kim Lévesque; Geoffrey A Wood; Kjersti M Aagaard-Tillery; Sylvain Meloche
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

2.  FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells.

Authors:  Hyun-Jung An; Cheol-Jung Lee; Ga-Eun Lee; Youngwon Choi; Dohyun Jeung; Weidong Chen; Hye Suk Lee; Han Chang Kang; Joo Young Lee; Dae Joon Kim; Jin-Sung Choi; Eun Suh Cho; Jong-Soon Choi; Yong-Yeon Cho
Journal:  Exp Mol Med       Date:  2022-01-12       Impact factor: 12.153

3.  Microtubule-associated proteins in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with granular cell layer dispersion.

Authors:  Ludmyla Kandratavicius; Mariana Raquel Monteiro; Jaime Eduardo Hallak; Carlos Gilberto Carlotti; Joao Alberto Assirati; Joao Pereira Leite
Journal:  Biomed Res Int       Date:  2013-08-27       Impact factor: 3.411

4.  Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats.

Authors:  Marlene F Shehata
Journal:  Cardiovasc Diabetol       Date:  2008-06-21       Impact factor: 9.951

5.  The non-classical MAP kinase ERK3 controls T cell activation.

Authors:  Miriam Marquis; Salix Boulet; Simon Mathien; Justine Rousseau; Paméla Thébault; Jean-François Daudelin; Julie Rooney; Benjamin Turgeon; Claudine Beauchamp; Sylvain Meloche; Nathalie Labrecque
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 6.  Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases.

Authors:  Toufic Kassouf; Grzegorz Sumara
Journal:  Biomolecules       Date:  2020-08-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.